- Home
- AMRX vs HAFN Comparison
AMRX vs HAFN Comparison
Compare AMRX & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- HAFN
- Stock Information
- Founded
- AMRX 2002
- HAFN 2012
- Country
- AMRX United States
- HAFN Singapore
- Employees
- AMRX N/A
- HAFN N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- HAFN
- Sector
- AMRX Health Care
- HAFN
- Exchange
- AMRX Nasdaq
- HAFN Nasdaq
- Market Cap
- AMRX 2.5B
- HAFN 2.7B
- IPO Year
- AMRX N/A
- HAFN N/A
- Fundamental
- Price
- AMRX $8.07
- HAFN $5.57
- Analyst Decision
- AMRX Strong Buy
- HAFN Strong Buy
- Analyst Count
- AMRX 4
- HAFN 1
- Target Price
- AMRX $11.50
- HAFN $6.50
- AVG Volume (30 Days)
- AMRX 1.5M
- HAFN 1.3M
- Earning Date
- AMRX 08-05-2025
- HAFN 08-27-2025
- Dividend Yield
- AMRX N/A
- HAFN 16.48%
- EPS Growth
- AMRX N/A
- HAFN N/A
- EPS
- AMRX N/A
- HAFN 1.20
- Revenue
- AMRX $2,830,186,000.00
- HAFN $2,631,664,000.00
- Revenue This Year
- AMRX $9.95
- HAFN N/A
- Revenue Next Year
- AMRX $8.14
- HAFN $1.88
- P/E Ratio
- AMRX N/A
- HAFN $4.61
- Revenue Growth
- AMRX 13.42
- HAFN N/A
- 52 Week Low
- AMRX $6.50
- HAFN $3.61
- 52 Week High
- AMRX $9.48
- HAFN $8.26
- Technical
- Relative Strength Index (RSI)
- AMRX 49.92
- HAFN N/A
- Support Level
- AMRX $7.79
- HAFN N/A
- Resistance Level
- AMRX $8.48
- HAFN N/A
- Average True Range (ATR)
- AMRX 0.20
- HAFN 0.00
- MACD
- AMRX -0.06
- HAFN 0.00
- Stochastic Oscillator
- AMRX 37.84
- HAFN 0.00
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.